Arena Pharmaceuticals, Inc. (ARNA)

[groverisproud]

It is both interesting and remarkable to me that ARNA's stock price is now considerably lower than it was after ADCOM but before FDA approval...especially given that many thought Belviq would not be approved. First novel obesity drug, it is now on the market and Arena has a highly regarded and successful marketing partner, coverage for the drug by insurance carriers is increasing, approvals and subsequent sales are expected in other countries in 2014, DTC advertising has begun in the US, but the price is trading below $5/ share. Seems quite fishy to me...especially since VVUS, a company that is hemorrhaging cash, has declining sales of Qysmia and can't find a marketing partner, just got upgraded.